Your browser does not support iframes.
N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Idenix Pharmaceuticals, Inc.
(NQ:
IDIX
)
4.310
USD
+0.120 (+2.86%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Idenix Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Klarman Baupost Gets Into Citi (C) Warrants, DIRECTV (DTV) and Elan (ELN); Cuts News Corp (NWSA)
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8337681 for the full story.
Read More
from
StreetInsider.com News Articles
Vertex (VRTX) VX-135 Looks Interesting, Thinks Deutsche Bank
May 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8299701 for the full story.
Read More
from
StreetInsider.com News Articles
Idenix Announces Data Presentation at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL)
April 08, 2013
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it will...
Read More
category
Benzinga
,
IDIX
,
News
from
Latest Articles from Benzinga.com
Bio-Wire Weekly: March 25th – March 29th 2013
April 01, 2013
The following was emailed over the weekend to subscribers of Bio-Wire Weekly (sign up today for free) Newsmakers 1.) Array Biopharma (NASDAQ: ARRY) Shares of ARRY moved up about 16% last week after...
Read More
category
RPRX
,
ZIOP
,
IDIX
, and 4 more.
from
Bio-Wire.Com
Biotech Movers: Analyst Upgrades Lift Puma
April 01, 2013
Read More
category
NASDAQ:IDIX
,
NASDAQ:ARIA
,
NASDAQ:ARRY
, and 3 more.
from
InvestorPlace - Latest Headlines
Mid-Afternoon Market Update: VrinetX Falls as Veeco Continues to Boost
March 25, 2013
Toward the end of trading Monday, the Dow traded down 0.48 percent to 14,452.18 while the NASDAQ dropped 0.33 percent to 3,234.06. The S&P also fell, dropping 0.38 percent to 1,551.26. Index...
Read More
category
Earnings
,
BBRY
,
Benzinga
, and 19 more.
from
Latest Articles from Benzinga.com
UPDATE: Bank of America Downgrades Idenix Pharmaceuticals to Underperform on Unfavorable Patent Ruling
March 25, 2013
In a report published Monday, Bank of America analyst Rachel McMinn downgraded the rating on Idenix Pharmaceuticals (NASDAQ: IDIX ) from Neutral to Underperform, and lowered the price target from $7.00...
Read More
category
Benzinga
,
Bank of America
,
IDIX
, and 3 more.
from
Latest Articles from Benzinga.com
Unusual 11 Mid-Day Movers 03/25: (STXS) (CHC) (HZNP) Higher; (PGTI) (IDIX) (TSL) Lower
March 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8209238 for the full story.
Read More
from
StreetInsider.com News Articles
Idenix Loses First Round To Gilead
March 25, 2013
The Patent Office ruled that Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) was the junior party in a patent dispute with Gilead Sciences (Nasdaq: GILD). Shares of Idenix fell 58 cents to $4.02 while...
Read More
from
MarketMinute.com Stock News
Idenix Pharmaceuticals (IDIX) stronger despite Gilead dispute
March 25, 2013
Idenix Pharmaceuticals (NASDAQ: IDIX) shares regained 0.4% to $4.60 after the company lost its first phase of a patent dispute with Gilead Sciences. Share volume was 485,000, compared to an all-day...
Read More
from
BAYSTREET RSS FEED
Investors look to Lighten Up on Shares of Idenix Pharmaceuticals, Shares Down 11.5% (IDIX)
March 25, 2013
from
Comtex SmarTrend® News Briefs
Higher Open As Cyprus Secures Bailout
March 25, 2013
The markets opened higher with the Dow rising 16 points to 14,528 after Cyprus reached a deal with the European Union to secure a bailout. Nasdaq added 7 points to 3252.
Read More
category
Market News
from
MarketMinute.com Market Updates
Morning Market Losers
March 25, 2013
CIFC (NASDAQ: CIFC) dropped 12.67% to $7.10 at 10:13 a.m. Top Ships (NASDAQ: TOPS ) shares dipped 11.20% to $1.19. Top Ships' trailing-twelve-month ROE is -12.37%. Idenix Pharmaceuticals (NASDAQ: IDIX...
Read More
category
Morning Market Losers
,
Benzinga
,
IDIX
, and 7 more.
from
Latest Articles from Benzinga.com
StreetInsider.com Pre-Open Movers 03/25: (APOL) (DG) (DELL) Higher; (OTT) (IDIX) (BBRY) Lower (more...)
March 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8208604 for the full story.
Read More
from
StreetInsider.com News Articles
Benzinga's Top Pre-Market Losers
March 25, 2013
Idenix Pharmaceuticals (NASDAQ: IDIX ) shares fell 8.70% to $4.20 in the pre-market trading after the company lost its first phase of a patent dispute with Gilead Sciences (NASDAQ: GILD ). United...
Read More
category
GLUU
,
BBRY
,
Benzinga
, and 8 more.
from
Latest Articles from Benzinga.com
Idenix Pharma (IDIX) Receives Adverse Decision in HCV Patent Filing; Will Appeal
March 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8206923 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE: JP Morgan Cuts PT to $13 on Idenix Pharmaceuticals on Model Update Post Q4
February 26, 2013
JP Morgan maintained Idenix Pharmaceuticals (NASDAQ: IDIX ) with an Overweight and lowers the price target from $15.00 to $13.00. JP Morgan noted, "Overall, we expect Idenix to make solid pipeline...
Read More
category
Benzinga
,
JP Morgan
,
IDIX
, and 3 more.
from
Latest Articles from Benzinga.com
Idenix Pharmaceuticals (IDIX) Reports In-Line Q4 Loss of 17c/Share
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8129651 for the full story.
Read More
from
StreetInsider.com News Articles
13-F Alert: Baupost Group Adds AIG Shares and Microsoft Call Options
February 13, 2013
Hedge funds are piling into shares of American International Group (NYSE: AIG ). The company's latest investor is the Baupost Group's Seth Klarman. The fund released its 13-F report for the...
Read More
category
ORCL
,
HPQ
,
Benzinga
, and 18 more.
from
Latest Articles from Benzinga.com
Klarman's Baupost Group Enters AIG (AIG), Trims Oracle (ORCL), Liquidates HP (HPQ)
February 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8093151 for the full story.
Read More
from
StreetInsider.com News Articles
New Stock Coverage: Get Your Kicks With Manchester United
February 12, 2013
With shares ending lower amid the most anemic volume of 2013 no wonder traders couldn’t wait to see the closing belles. Markets moved to the downside after Goldman Sachs (GS) which appears to be...
Read More
from
Minyanville Headlines
Baird Starts Idenix Pharmaceuticals Inc. (IDIX) at Neutral; No Great Pipeline but Patents Could Have Value
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8080561 for the full story.
Read More
from
StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 02/05: (OPXA) (PLX) (VMED) Higher; (HEB) (YUM) (JCP) Lower (more...)
February 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8059467 for the full story.
Read More
from
StreetInsider.com News Articles
Streetinsider.com After-Hours Movers 2/4: (THO) (CI) (SWI) Higher; (YUM) (BIDU) (HOLX) Lower (more...)
February 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8057458 for the full story.
Read More
from
StreetInsider.com News Articles
Idenix Pharma Will Cease IDX 184, IDX 19368
February 04, 2013
Shares of Idenix Pharma (NASDAQ: IDIX ) were halted during after-hours trading Monday. The company announced that it has "elected not to continue its clinical development program" for IDX184. In...
Read More
category
Benzinga
,
Movers
,
IDIX
, and 3 more.
from
Latest Articles from Benzinga.com
UPDATE: Idenix Pharma to Discontinue IDX184, IDX19368 Programs
February 04, 2013
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the Company has...
Read More
category
Benzinga
,
IDIX
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
Idenix Pharma (IDIX) to Cease IDX184, IDX19368 Programs
February 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8056345 for the full story.
Read More
from
StreetInsider.com News Articles
Idenix Pharmaceuticals (IDIX) halted, news pending
February 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8056215 for the full story.
Read More
from
StreetInsider.com News Articles
Downgrade Alert for Idenix Pharmaceuticals (IDIX)
January 30, 2013
from
Comtex SmarTrend® News Briefs
Wedbush Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Neutral
January 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8041653 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.